Google News

  1. AZN Stock Jumps On $2 Billion Bet In Weight-Loss Drugs  Investor’s Business Daily
  2. AstraZeneca enters weight-loss market with oral GLP-1 drug  Yahoo Finance
  3. AstraZeneca pays $185M upfront to reenter oral obesity gold rush, drops phase 2 sickle cell drug  FierceBiotech
  4. AstraZeneca CFO: Obesity Market Has a Lot of Potential  Bloomberg Television
  5. AstraZeneca makes big push into weight-loss market with obesity pill deal  The Guardian
  6. View Full Coverage on Google News

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *